These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 214127)

  • 61. Characteristics of the cyclic nucleotide phosphodiesterases in a transplantable pheochromocytoma and adrenal medulla of the rat.
    Levin RM; Weiss B
    Cancer Res; 1978 Apr; 38(4):915-20. PubMed ID: 205349
    [No Abstract]   [Full Text] [Related]  

  • 62. Cyclic nucleotide phosphodiesterase localization in nerve terminals of the rat substantia nigra.
    Minneman KP; Cuello AC
    J Neurochem; 1979 Aug; 33(2):587-91. PubMed ID: 224146
    [No Abstract]   [Full Text] [Related]  

  • 63. Multiple forms of cyclic nucleotide phosphodiesterases in normal and goitrous rat thyroid.
    Sharma RV; Bhalla RC
    Arch Biochem Biophys; 1980 Jun; 202(1):210-20. PubMed ID: 6249217
    [No Abstract]   [Full Text] [Related]  

  • 64. Characterization of a human melanoma cell line (KHm-1) containing phosphodiesterase activity only for cyclic adenosine 3':5'-monophosphate.
    King LE; Solomon SS; Hashimoto K
    Cancer Res; 1978 Nov; 38(11 Pt 1):3879-85. PubMed ID: 29705
    [No Abstract]   [Full Text] [Related]  

  • 65. 2',3'-cyclic neucleotide 3'-phosphodiesterase activity in developing rat brain.
    Singh R; Shankar R
    Indian J Physiol Pharmacol; 1998 Jan; 42(1):147-50. PubMed ID: 9513810
    [No Abstract]   [Full Text] [Related]  

  • 66. A partial characterization of the cyclic nucleotide phosphodiesterases of Drosophila melanogaster.
    Davis RL; Kiger JA
    Arch Biochem Biophys; 1980 Aug; 203(1):412-21. PubMed ID: 6250491
    [No Abstract]   [Full Text] [Related]  

  • 67. Selective alteration of Ca2+-dependent and Ca2+-independent cyclic nucleotide phosphodiesterase activity in rat cerebral cortex by cyclic nucleotides and their analogs.
    Davis CW
    Biochim Biophys Acta; 1982 Jul; 705(1):1-7. PubMed ID: 6288105
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cell-cycle-specific activity of cyclic nucleotide phosphodiesterase in Physarum polycephalum.
    Kupetz IS; Jeter JR
    Cell Tissue Kinet; 1985 Mar; 18(2):159-68. PubMed ID: 2982493
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Selective inhibition of separated forms of cyclic nucleotide phosphodiesterase from rat heart by some pentasubstituted quercetin analogs.
    Picq M; Prigent AF; Nemoz G; Pacheco H
    Biochem Pharmacol; 1982 Sep; 31(17):2777-82. PubMed ID: 6291544
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Methylxanthine inhibitors of phosphodiesterases.
    Wells JN; Miller JR
    Methods Enzymol; 1988; 159():489-96. PubMed ID: 2457788
    [No Abstract]   [Full Text] [Related]  

  • 71. Evidence for convertible forms of soluble uterine cyclic nucleotide phosphodiesterase.
    Strada SJ; Epstein PM; Gardner EA; Thompson WJ; Stancel GM
    Biochim Biophys Acta; 1981 Sep; 661(1):12-20. PubMed ID: 6271215
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Inhibitory effects of flavonoids on phosphodiesterase isozymes from guinea pig and their structure-activity relationships.
    Ko WC; Shih CM; Lai YH; Chen JH; Huang HL
    Biochem Pharmacol; 2004 Nov; 68(10):2087-94. PubMed ID: 15476679
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Selective inhibition of rat lung cyclic AMP phosphodiesterase and cyclic GMP phosphodiesterase by cyclic nucleotides and their analogues and various drugs [proceedings].
    Butt NM; Saeed SA; Collier HO
    Biochem Soc Trans; 1980 Jun; 8(3):380-1. PubMed ID: 6249674
    [No Abstract]   [Full Text] [Related]  

  • 74. Phosphodiesterases and regulation of female reproductive function.
    Conti M
    Curr Opin Pharmacol; 2011 Dec; 11(6):665-9. PubMed ID: 22019564
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Antiplatelet effects of KW-7, a new inhibitor of cyclic nucleotide phosphodiesterases.
    Wu CC; Wang WY; Kuo RY; Chang FR; Wu YC
    Eur J Pharmacol; 2004 Jan; 483(2-3):187-94. PubMed ID: 14729106
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Cyclic nucleotide phosphodiesterase of normal and leukemic lymphocytes. Kinetic properties and selective alteration of the activity of the multiple molecular forms.
    Hait WN; Weiss B
    Mol Pharmacol; 1979 Nov; 16(3):851-64. PubMed ID: 231197
    [No Abstract]   [Full Text] [Related]  

  • 77. Effect of trifluoperazine on cyclic nucleotide phosphodiesterase activity in crude homogenates of bovine adrenal medulla.
    Crimaldi AA; Kuo IC; Coffee CJ
    Ann N Y Acad Sci; 1980; 356():367-8. PubMed ID: 6263155
    [No Abstract]   [Full Text] [Related]  

  • 78. Effect of calcium on cyclic nucleotide phosphodiesterase in parathyroid tissue.
    Willgoss D; Jacobi JM; de Jersey J; Bartley PC; Lloyd HM
    Biochem Biophys Res Commun; 1980 Jun; 94(3):763-8. PubMed ID: 6249291
    [No Abstract]   [Full Text] [Related]  

  • 79. Cyclic nucleotide phosphodiesterase. Insulin activation detected in adipose tissue by gel electrophoresis.
    Solomon SS; Palazzolo M; King LE
    Diabetes; 1977 Oct; 26(10):967-72. PubMed ID: 198322
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Dissimilar cyclic nucleotide phosphodiesterase activities in subcellular fractions from normal and SV40-transformed WI-38 fibroblasts.
    Nemecek GM; Butcher RW
    J Cyclic Nucleotide Res; 1979 Dec; 5(6):449-61. PubMed ID: 94064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.